Authors
Khloud Mubarak Algothmi, Nada Fahad Alwathinani, Sayed Sartaj Sohrab, Esam Ibraheem Azhar
Published in
The new microbiologica. Volume 49. Issue 2. Pages 83-93.
Abstract
Viral respiratory tract infections, particularly Human Bocavirus (HBoV) infections, are a significant global health concern. COVID-19 has provided a suitable platform for infectious diseases caused by multiple pathogens. This review highlights key aspects of the current status and future prospects of HBoV research in the Kingdom of Saudi Arabia, including global and local prevalence, clinical impact, and diagnostic challenges. It also emphasizes the need for future research, particularly in Saudi Arabia, to fill knowledge gaps, improve diagnosis, and design and develop future treatment and prevention strategies. HBoV was identified from a ten-year-old infected patient in Sweden from collected nasopharyngeal samples in 2005. It has been classified into four genotypes (1-4), and HBoV-1 causes respiratory infections requiring hospitalization. Co-infections with other viruses are well known, with the most common symptoms being pneumonia, cough, fever, and wheezing. Most studies on HBoV diagnosis have relied primarily on polymerase chain reaction techniques. Even though pediatric HBoV infections are common worldwide, due to limited HBoV research, there is a lack of awareness among healthcare providers, especially in Saudi Arabia and the Middle East & North Africa region. Expanding research and awareness on HBoV is urgently required to address the burden of respiratory infections in these regions, not only to explore long-term effects, potential treatments, and vaccine development, but also to use advanced diagnostic methods to analyze the changing epidemiology of respiratory pathogens and achieve effective infection control measures.
PMID:
42507119
Bibliographic data and abstract were imported from PubMed on 27 Jul 2026.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0